Cutler Group’s Legend Biotech LEGN Stock Holding History

Cutler Group’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$4K	Sell	1,300 -9,600	-88%	-$579K	﹤0.01%	1638
2023 Q4	$4K	Buy	10,900 +8,400	+336%	+$532K	﹤0.01%	2844
2023 Q3	$12K	Buy	+2,500	New	+$174K	﹤0.01%	2371
2023 Q2	–	Sell	-1,200	Closed	-$1K	–	3910
2023 Q1	$1K	Sell	1,200 -19,400	-94%	-$949K	﹤0.01%	3472
2022 Q4	$18K	Buy	20,600 +600	+3%	+$29.1K	﹤0.01%	2291
2022 Q3	$67K	Sell	20,000 -4,600	-19%	-$216K	﹤0.01%	1688
2022 Q2	$382K	Buy	24,600 +20,500	+500%	+$866K	0.03%	655
2022 Q1	$30K	Buy	+4,100	New	+$162K	﹤0.01%	2695

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Cutler Group's LEGN Position: Q1 2024 in Review

Cutler Group opened a new position in Legend Biotech (LEGN) in Q1 2024: 1,900 shares worth $106K. The stake represents 0.03% of the portfolio and ranks #437 among its holdings. This is a return to the name: Cutler Group previously reported a position in LEGN as recently as Q4 2022.

Cutler Group first reported a position in LEGN in Q1 2022 and has held it in 3 quarters since. 192 funds tracked by Wall St. Rank hold LEGN as of Q1 2024.

Cutler Group held 1,900 shares of Legend Biotech worth $106K as of Q1 2024.
Legend Biotech was a new Cutler Group position in Q1 2024.
Legend Biotech made up 0.03% of Cutler Group's portfolio in Q1 2024, its #437 holding.
Cutler Group first reported a position in Legend Biotech in Q1 2022 and has held it in 3 quarters since.
192 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.